Fermer le menu

 

Member of Lyonbiopole

 

Orixha’s mission is to develop Liquid Ventilation Medical Devices to save lives in Critical Care.

Orixha is developing the Vent2Cool medical device to almost immediately protect the vitals organs, in particular the brain and heart, of patients resuscitated after cardiac arrest and thus significantly reduce mortality and morbidity. Vent2Cool turns the lungs into a heat exchanger with the blood compartment. This makes it possible to induce ultra-rapid therapeutic hypothermia in minutes where current hypothermia solutions take hours to reach the target temperature of 33°C.

 

Application market: Cardiology, Intensive care medicine, Pneumology - Respiratory Diseases

Type of activity: Medical device

Technologies: Disposable & Implants

Created on may 31st, 2018 - 8 employees

 

Address

24 rue Laure Diebold 69009 Lyon

 

Contacts

Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.